Parenteral methotrexate or gold for rheumatoid arthritis: a follow up

Clin Exp Rheumatol. 1990 Mar-Apr;8(2):163-6.


The forty participants in a double blind controlled trial of parenteral methotrexate or gold for RA were followed up two years later. Fifty percent had remained on the original medication, 13/20 on MTX and 7/20 on gold. Only 5 and 3 of them respectively had no active joint swelling. No major differences between the two groups were seen.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arthritis, Rheumatoid / drug therapy*
  • Drug Administration Schedule
  • Follow-Up Studies
  • Gold Sodium Thiomalate / administration & dosage*
  • Gold Sodium Thiomalate / adverse effects
  • Gold Sodium Thiomalate / therapeutic use
  • Humans
  • Infusions, Parenteral
  • Methotrexate / administration & dosage*
  • Methotrexate / adverse effects
  • Methotrexate / therapeutic use
  • Patient Dropouts
  • Time Factors


  • Gold Sodium Thiomalate
  • Methotrexate